The goal of the 100 Days Mission is to make vaccines, therapeutics and diagnostics available within 100 days of any future pandemic.
Policy and advocacy
Through campaigns and partnerships, Wellcome brings together people and resources from across society to get the most out of research. It’s how we make sure great ideas improve health, as quickly as possible, for everyone.
What we do
We focus on the world's biggest health challenges and supporting the best possible environment for researchers to thrive.
Our work with researchers and policy makers – as well as commercial, charitable and non-governmental organisations around the world – informs decisions about science and health, and provides strong evidence for coordinated global action.
Areas we work in
We want to help the world overcome Covid-19. We’re calling for urgent international action to get lifesaving tests, treatments and vaccines from the laboratory to the front line, so they reach those most in need around the world.
Current practices prioritise outputs over people’s wellbeing. We want to help build a better research culture – one that is creative, inclusive and honest.
The collective overuse of antibiotics has caused one of the most urgent health problems. We want to transform the world's response towards stemming the rise of drug-resistant infections.
Vaccines prevent disease, save countless lives and cut healthcare costs. We want to help develop new vaccines and work out how to use the existing ones in a better way.
The human and economic cost of epidemics is unsustainable. Effective research and coordinated action stop outbreaks spiralling into global health emergencies.
We worked with EU institutions, the UK government, the research sector and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.
Artificial intelligence (AI) and data technologies are transforming research and healthcare. We want to make sure everyone benefits from health data innovation.
Latest reports and briefings
A roadmap to making lifesaving monoclonal antibody treatments affordable and available, particularly to those living in low- and middle-income countries.
Perspectives on and experiences of research culture, based on a survey of more than 4,000 researchers in the UK and globally.
The world’s largest study into how people around the world think and feel about science and major health challenges.
Director of Strategy
Head of Policy, Infectious Disease
Head of Policy Lab
Senior Policy Adviser